Cargando…

Serine protease inhibitor kazal-type 6 inhibits tumorigenesis of human hepatocellular carcinoma cells via its extracellular action

Hepatocellular carcinoma (HCC) causes significant medical burdens worldwide. Diagnosis, especially in the early stages, is still challenging. Therapeutic options are limited and often ineffective. Although several risk factors have been known important for development of HCC, the molecular basis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Kuikui, Huang, Jinjiang, Wang, Wei, Gu, Meigang, Dai, Xinchuan, Xu, Yuqiang, Wu, Hongyu, Li, Guodong, Lu, Hairong, Zhong, Jiang, Huang, Qingshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351605/ https://www.ncbi.nlm.nih.gov/pubmed/27999203 http://dx.doi.org/10.18632/oncotarget.13983

Ejemplares similares

Generation and Analysis of Serine Protease Inhibitor Kazal Type 3-Cre Driver Mice
por: Sakata, Kazuya, et al.
Publicado: (2014)

Liver Cancer–Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma
por: Lu, Felix, et al.
Publicado: (2020)

Regulation of serine protease inhibitor Kazal type-5 (SPINK5) gene expression in the keratinocytes
por: Le, Ngoc Anh, et al.
Publicado: (2014)

LAMP2: a major update of the database linking antimicrobial peptides
por: Ye, Guizi, et al.
Publicado: (2020)

EnzyBase: a novel database for enzybiotic studies
por: Wu, Hongyu, et al.
Publicado: (2012)

GMEnzy: A Genetically Modified Enzybiotic Database
por: Wu, Hongyu, et al.
Publicado: (2014)

Kazal-type serine proteinase inhibitors in the midgut of Phlebotomus papatasi
por: Sigle, Leah Theresa, et al.
Publicado: (2013)

Genetic polymorphisms in serine protease inhibitor Kazal-type 5 and risk of atopic dermatitis: A meta-analysis
por: Li, Yunling, et al.
Publicado: (2020)

A Kazal-Type Serine Protease Inhibitor from the Defense Gland Secretion of the Subterranean Termite Coptotermes formosanus Shiraki
por: Negulescu, Horia, et al.
Publicado: (2015)

Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease
por: Caviglia, Gian Paolo, et al.
Publicado: (2022)

Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma
por: Jia, Jianlong, et al.
Publicado: (2022)

Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers
por: Mehner, Christine, et al.
Publicado: (2015)

Molecular Cloning and Functional Studies of Two Kazal-Type Serine Protease Inhibitors Specifically Expressed by Nasonia vitripennis Venom Apparatus
por: Qian, Cen, et al.
Publicado: (2015)

A two disulfide bridge Kazal domain from Phytophthora exhibits stable inhibitory activity against serine proteases of the subtilisin family
por: Tian, Miaoying, et al.
Publicado: (2005)

Hepatitis B Virus X Protein-Induced Serine Protease Inhibitor Kazal Type 1 Is Associated with the Progression of HBV-Related Diseases
por: Zhu, Chengliang, et al.
Publicado: (2019)

Structural Basis for Dual-Inhibition Mechanism of a Non-Classical Kazal-Type Serine Protease Inhibitor from Horseshoe Crab in Complex with Subtilisin
por: Shenoy, Rajesh T., et al.
Publicado: (2011)

High Prevalence of Serine Protease Inhibitor Kazal Type 1 Gene Variations Detected by Whole Gene Sequencing in Patients with Fibrocalculous Pancreatic Diabetes
por: Kolly, Anish, et al.
Publicado: (2017)

A Hypothesized Mechanism for Chronic Pancreatitis Caused by the N34S Mutation of Serine Protease Inhibitor Kazal-Type 1 Based on Conformational Studies
por: Kulke, Martin, et al.
Publicado: (2021)

Extracellular: Plasma Membrane Proteases – Serine Proteases
por: Antalis, T.M., et al.
Publicado: (2016)

The impact of physiological stress conditions on protein structure and trypsin inhibition of serine protease inhibitor Kazal type 1 (SPINK1) and its N34S variant
por: Buchholz, Ina, et al.
Publicado: (2020)

The Prevalence of Cationic Trypsinogen (PRSS1) and Serine Protease Inhibitor, Kazal Type 1 (SPINK1) Gene Mutations in Polish Patients with Alcoholic and Idiopathic Chronic Pancreatitis
por: Gasiorowska, Anita, et al.
Publicado: (2010)

Tazarotene-Induced Gene 1 (TIG1) Interacts with Serine Protease Inhibitor Kazal-Type 2 (SPINK2) to Inhibit Cellular Invasion of Testicular Carcinoma Cells
por: Shyu, Rong-Yaun, et al.
Publicado: (2019)

Serine protease inhibitor Kazal type 1 (SPINK1) promotes proliferation, migration, invasion and radiation resistance in rectal cancer patients receiving concurrent chemoradiotherapy: a potential target for precision medicine
por: Chen, Yi-Ting, et al.
Publicado: (2022)

Extracellular Pneumococcal Serine Proteases Affect Nasopharyngeal Colonization
por: Ali, Murtadha Q., et al.
Publicado: (2021)

Serine Protease Inhibitor Kazal Type 1 (SPINK1) c.194+2T > C Mutation May Predict Long-term Outcome of Endoscopic Treatments in Idiopathic Chronic Pancreatitis
por: Sun, Chang, et al.
Publicado: (2015)

DrugSig: A resource for computational drug repositioning utilizing gene expression signatures
por: Wu, Hongyu, et al.
Publicado: (2017)

Inhibitors of Serine Proteases in Regulating the Production and Function of Neutrophil Extracellular Traps
por: Majewski, Pawel, et al.
Publicado: (2016)

Pneumococcal Extracellular Serine Proteases: Molecular Analysis and Impact on Colonization and Disease
por: Ali, Murtadha Q., et al.
Publicado: (2021)

LAMP: A Database Linking Antimicrobial Peptides
por: Zhao, Xiaowei, et al.
Publicado: (2013)

MAPK inhibitors induce serine peptidase inhibitor Kazal type 1 (SPINK1) secretion in BRAF V600E‐mutant colorectal adenocarcinoma
por: Räsänen, Kati, et al.
Publicado: (2017)

The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Extracellular Proteolysis of Apolipoprotein E (apoE) by Secreted Serine Neuronal Protease
por: Tamboli, Irfan Y., et al.
Publicado: (2014)

Identification of Lympho-Epithelial Kazal-Type Inhibitor 2 in Human Skin as a Kallikrein-Related Peptidase 5-Specific Protease Inhibitor
por: Meyer-Hoffert, Ulf, et al.
Publicado: (2009)

The role of Serine Proteases and Serine Protease Inhibitors in the migration of Gonadotropin-Releasing Hormone neurons
por: Drapkin, Paola T, et al.
Publicado: (2002)

Downregulating serine hydroxymethyltransferase 2 (SHMT2) suppresses tumorigenesis in human hepatocellular carcinoma
por: Woo, Chern Chiuh, et al.
Publicado: (2016)

Dependence and Guidance Receptors—DCC and Neogenin—In Partial EMT and the Actions of Serine Proteases
por: Stone, Trevor W.
Publicado: (2020)

Serine Proteases of Parasitic Helminths
por: Yang, Yong, et al.
Publicado: (2015)

Proteolytic cleavages in the extracellular domain of receptor tyrosine kinases by membrane-associated serine proteases
por: Chen, Li-Mei, et al.
Publicado: (2017)

Hypermethylation of the 5′ CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis
por: Manton, K J, et al.
Publicado: (2005)

The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis
por: Bergeron, Sébastien, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_d10t3k9lfs3fdo3hiajt71tdod